Nanoscale · 2024 · 22 citations · 51 references
PharmacyOncologyPharmaceuticsDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryCancer Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsCancer NanotherapyDendrimer Drug DeliveryDendrimer-based DeliveryDrug-related Side EffectsNanoparticle-based ChemotherapySystemic Adverse EffectsSystemic DeliverySystemic Drug Delivery
We present PD-CTT1298 nanoplatform as a versatile approach for selective systemic delivery of high payloads of potent chemotherapeutics to PSMA (+) prostate cancer, where dose related systemic side-effects are a major concern.
51
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Ghassan K. Abou‐Alfa, Tim Meyer, Ann‐Lii Cheng et al. · New England Journal of Medicine · 2018 · 2.3K citations · Full text
Medicine, Oncology, Pharmacology +16
Structure of PAMAM Dendrimers: Generations 1 through 11
Prabal K. Maiti, Tahir Çağın, Guofeng Wang et al. · Macromolecules · 2004 · 522 citations